Dupilumab (Dupixent®) for severe, uncontrolled asthma 8 Sep 2020
Allergy & Anaphylaxis Australia (A&AA) made a submission to Pharmaceutical Benefits Advisory Committee (PBAC)
Dupilumab (Dupixent®) for severe, uncontrolled asthma 8 Sep 2020190.06 KB